Implanon NXT, 68 mg, implant for subdermal use

  • DHPC
Company
Organon Pharma (Ireland) Limited
Active Ingredient
Strength
  • 68 mg
Dosage Form
Implant
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026

Direct Healthcare Professional Communications

  • Signal Assessment on meningioma risk

    Direct Healthcare Professional Communication (DHPC)

    PDF210.91 KB

Organon Pharma (Ireland) Limited

2 Dublin Landings, N Wall Quay - North Dock, Dublin, D01 V4A3

Telephone
+35315828260
Email
medinfo.roi@organon.com